Sign in to follow
Search Results

0 results for 'Valeant Pharmaceuticals International, Inc.'

You can use to get even better search results
November 02, 2015 | Law.com

Big Deals

Schlumberger / Cameron Schlumberger Ltd. is using Baker Botts and Gibson, Dunn & Crutcher for its pending $14.8 billion acquisition of Cameron International,…
7 minute read
August 20, 2015 |

Deal Watch: 'Female Viagra' Spawns More Skadden, S&C Deal Work

Sprout Pharmaceuticals didn't have to wait long for a big-name buyer to spring big bucks for the nascent drug developer. Sullivan & Cromwell took the lead for the company, founded in 2011, on its $1 billion sale this week to longtime Skadden, Arps, Slate, Meagher & Flom client Valeant Pharmaceuticals International.
6 minute read
August 20, 2015 |

Mergers & Acquisitions

New Jersey Mergers & Acquisitions.
1 minute read
August 20, 2015 | Law.com

Deal Watch: 'Female Viagra' Spawns More Skadden, S&C Deal Work

Sprout Pharmaceuticals didn't have to wait long for a big-name buyer to spring big bucks for the nascent drug developer. Sullivan & Cromwell took the lead for the company, founded in 2011, on its $1 billion sale this week to longtime Skadden, Arps, Slate, Meagher & Flom client Valeant Pharmaceuticals International.
6 minute read
August 20, 2015 | Law.com

Mergers & Acquisitions

New Jersey Mergers & Acquisitions.
1 minute read
June 01, 2015 |

June Deals & Suits

11 minute read
May 28, 2015 |

Lessons of DuPont: Corporate Governance for Dummies

In his Corporate Securities column, John C. Coffee Jr., the Adolf A. Berle Professor of Law at Columbia University Law School, analyzes some obvious truths that stand out in the recent battle between Trian Fund Management and DuPont that will apply to future contests.
16 minute read
May 22, 2015 |

Dealmakers of the Week: Eileen Nugent and C. Michael Chitwood of Skadden, Arps, Slate, Meagher & Flom

The two Skadden transactional lawyers advised Endo Pharmaceuticals on its $8.05 billion buy of generic-drug maker Par Pharmaceuticals from private equity firm TPG Capital.
5 minute read
May 22, 2015 | Law.com

Dealmakers of the Week: Eileen Nugent and C. Michael Chitwood of Skadden, Arps, Slate, Meagher & Flom

The two Skadden transactional lawyers advised Endo Pharmaceuticals on its $8.05 billion buy of generic drug maker Par Pharmaceuticals from private equity firm TPG Capital.
5 minute read
May 21, 2015 |

Deal Watch: Four Am Law 100 Firms Prescribed Work on CVS-Omnicare Merger

Firms Prescribed Work on $12.7 Billion CVS, Omnicare Deal
6 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now